No pharmacy availability date has been announced for any of Wednesday's five approved products
Applicable Procedure Codes: J0470, J0600, J0895, J3490, J3520, J8499, M0300, S9355
"We look forward to meeting our goal of bringing an important new therapy to people living with this condition, including sharing more detailed results at scientific congresses and submitting to regulatory authorities later this year." The complete SURPASS-4 study data are being evaluated and additional results will be presented at the 57 th Annual Meeting of the European Association for the Study of Diabetes and published in a peer-reviewed journal
Cash-pay options Depending on the specific drug prescribed, you may be able to get it at a lower price if you opt for the cash-pay options
Escalation and Maintenance Dosage (Days 31 and beyond) : Days 31 to 60: Increase the dosage to 7 mg orally once daily
We monitor your weight, tolerance, and any side effects in person to ensure you are responding safely and that your treatment continues to be appropriate